{"id":71303,"date":"2026-11-17T19:19:43","date_gmt":"2026-11-17T19:19:43","guid":{"rendered":"https:\/\/cp.snarskis.lt\/index.php\/2026\/11\/17\/di-vaistu-kureja-isomorphic-labs-pritrauke-45-mlrd-euru-vienas-didziausiu-raundu-europoje\/"},"modified":"2026-11-17T19:19:43","modified_gmt":"2026-11-17T19:19:43","slug":"di-vaistu-kureja-isomorphic-labs-pritrauke-45-mlrd-euru-vienas-didziausiu-raundu-europoje","status":"publish","type":"post","link":"https:\/\/cp.snarskis.lt\/index.php\/2026\/11\/17\/di-vaistu-kureja-isomorphic-labs-pritrauke-45-mlrd-euru-vienas-didziausiu-raundu-europoje\/","title":{"rendered":"DI vaist\u0173 k\u016br\u0117ja \u201eIsomorphic Labs\u201c pritrauk\u0117 4,5 mlrd. eur\u0173 \u2013 vienas did\u017eiausi\u0173 raund\u0173 Europoje"},"content":{"rendered":"<p>Dirbtiniu intelektu paremtus vaist\u0173 k\u016brimo sprendimus vystanti \u201eIsomorphic Labs\u201c paskelb\u0117 pritraukusi 4,5 mlrd. eur\u0173 (5 mlrd. JAV doleri\u0173) C serijos investicij\u0105.<\/p>\n<p>Apie \u0161\u012f finansavimo raund\u0105 prane\u0161\u0117 portalas \u201eEU-Startups\u201c. Skelbiama, kad investicija skirta paspartinti tiek mokslinius prover\u017eius, tiek bendrov\u0117s kuriamas patentuotas DI technologijas.<\/p>\n<p>Raundui bendrai vadovavo \u201eGreenoaks\u201c ir \u201eSequoia Capital\u201c, dalyvavo \u201eAndreessen Horowitz\u201c, o \u201eAlphabet\u201c t\u0119s\u0117 reik\u0161mingas investicijas. Prie raundo prisid\u0117jo ir esami investuotojai: \u201eThrive Capital\u201c, MGX, GV, \u201eCapitalG\u201c, \u201eTemasek\u201c bei JK \u201eSovereign AI Fund\u201c.<\/p>\n<p>Bendrov\u0117s vadovas ir \u012fk\u016br\u0117jas Demis Hassabis teigia, kad tikslas \u2013 kurti fundamentinius biologijos modelius, gilinti sistemini\u0173 lig\u0173 supratim\u0105 ir pirm\u0105sias terapines programas stumti link klinikini\u0173 tyrim\u0173.<\/p>\n<h2>Europos DI biotechnologij\u0173 kontekstas<\/h2>\n<p>\u201eIsomorphic Labs\u201c finansavimo dydis ry\u0161kiai i\u0161siskiria i\u0161 kit\u0173 2026 metais Europoje fiksuot\u0173 investicij\u0173 \u012f DI paremt\u0105 vaist\u0173 paie\u0161k\u0105 ir farmacinius tyrimus.<\/p>\n<p>Jungtin\u0117je Karalyst\u0117je Londono \u201eHelical\u201c pritrauk\u0117 8,4 mln. eur\u0173 virtualiai DI laboratorijai, \u201eTernary Therapeutics\u201c \u2013 4,1 mln. eur\u0173, o \u201eSable Bio\u201c \u2013 3,15 mln. eur\u0173 vaist\u0173 saugos platformai.<\/p>\n<p>Pranc\u016bzijoje \u201eOrakl Oncology\u201c paskelb\u0117 apie 30 mln. eur\u0173 investicij\u0105, \u201eRivercell\u201c \u2013 apie 22 mln. eur\u0173, o \u0160veicarijoje veikianti \u201eAdaptyv Bio\u201c \u2013 apie 34,35 mln. eur\u0173 finansavim\u0105 automatizuotam biologiniam testavimui.<\/p>\n<h2>Kuo u\u017esiima \u201eIsomorphic Labs\u201c<\/h2>\n<p>\u201eIsomorphic Labs\u201c \u012fkurta 2021 metais. Bendrov\u0117 teigia suk\u016brusi DI vaist\u0173 dizaino varikl\u012f, kuris remiasi fundamentiniais modeliais ir gali b\u016bti taikomas skirtingoms terapin\u0117ms sritims bei vaist\u0173 tipams.<\/p>\n<p>Bendrov\u0117 taip pat nurodo ple\u010dianti savo patentuot\u0105 vaist\u0173 dizaino sistem\u0105 \u201eIsoDDE\u201c ir DI sukurt\u0173 terapini\u0173 kandidat\u0173 krypt\u012f.<\/p>\n<p>Pasak \u012fmon\u0117s, \u201eIsoDDE\u201c suvienija simuliacijomis paremt\u0173 fundamentini\u0173 modeli\u0173 rinkin\u012f, o sistema leid\u017eia tyrin\u0117ti itin pla\u010dias chemini\u0173 jungini\u0173 \u201eerdves\u201c ir atrinkti molekules su tinkamesn\u0117mis vaistin\u0117mis savyb\u0117mis.<\/p>\n<h2>Kur bus panaudotos investicijos<\/h2>\n<p>Skelbiama, kad pritrauktas kapitalas bus naudojamas toliau brandinti \u201eIsoDDE\u201c, gilintis \u012f nauj\u0105 biologij\u0105 pasitelkiant pa\u017eangesnius modelius ir kurti partneri\u0173 ekosistem\u0105, kuri pad\u0117t\u0173 geriau suprasti lig\u0173 mechanizmus.<\/p>\n<p>Be to, bendrov\u0117 planuoja pl\u0117sti infrastrukt\u016br\u0105, reikaling\u0105 DI vedamai bioin\u017einerijai, ir stiprinti DI orientuot\u0105 translacini\u0173 bei klinikini\u0173 tyrim\u0173 vystymo paj\u0117gum\u0105.<\/p>\n<p>\u012emon\u0117s prezidentas Maxas Jaderbergas pabr\u0117\u017eia, kad j\u0173 modeliai es\u0105 kas savait\u0119 leid\u017eia pasiekti pakartojam\u0173 mokslini\u0173 pa\u017eang\u0173, kurios virsta geresniais molekuli\u0173 profiliais ir potencialiais naujais vaistais.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>DI vaist\u0173 k\u016brimo bendrov\u0117 \u201eIsomorphic Labs\u201c pritrauk\u0117 4,5 mlrd. eur\u0173 C serijos investicij\u0105 ir \u017eada greitinti keli\u0105 link klinikini\u0173 tyrim\u0173.<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[94],"tags":[2363,4858,57018,57019,16512,1031,1040],"miestas":[],"class_list":["post-71303","post","type-post","status-publish","format-standard","hentry","category-finansai","tag-alphabet","tag-andreessen-horowitz","tag-demis-hassabis","tag-greenoaks","tag-isomorphic-labs","tag-sequoia-capital","tag-startuoliai"],"acf":[],"_links":{"self":[{"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/posts\/71303","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/comments?post=71303"}],"version-history":[{"count":0,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/posts\/71303\/revisions"}],"wp:attachment":[{"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/media?parent=71303"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/categories?post=71303"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/tags?post=71303"},{"taxonomy":"miestas","embeddable":true,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/miestas?post=71303"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}